Lotus Pharmaceuticals Inc. (OTCMKTS:LTUS – Get Free Report) was the target of a significant growth in short interest during the month of June. As of June 30th, there was short interest totaling 316 shares, a growth of ? from the June 15th total of 0 shares. Based on an average trading volume of 3,300 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.0% of the company’s stock are sold short.
Lotus Pharmaceuticals Price Performance
LTUS opened at $0.00 on Thursday. Lotus Pharmaceuticals has a 1 year low of $0.00 and a 1 year high of $0.01.
Lotus Pharmaceuticals Company Profile
Lotus Pharmaceuticals, trading under the symbol LTUS on the OTC Market, is a Taiwan-based pharmaceutical company specializing in the research, development, manufacturing and marketing of prescription medications. The company’s core operations encompass both the production of a broad range of generic drugs and the advancement of novel compounds aimed at therapeutic areas such as oncology, central nervous system disorders, cardiovascular diseases and anti-infective treatments.
Lotus Pharmaceuticals offers multiple dosage forms, including tablets, capsules, injectables and sterile preparations, to meet the needs of hospital and retail pharmacy channels.
Featured Stories
- Five stocks we like better than Lotus Pharmaceuticals
- Why Johnson & Johnson’s Earnings Dip Looks Like a Buying Opportunity
- CPI Comes In Cool: Why It Could Revive These 3 Rate-Sensitive Stocks
- Why ASML’s AI Monopoly Is Still Getting Stronger
- Apple’s AI Toll Booth Thesis Faces Its Biggest Test Yet Before Earnings
Receive News & Ratings for Lotus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lotus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
